December #192 : Cure: Drug-Free Viral Control in Monkeys - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Features

The POZ 100: Celebrating Unsung Heroes

The POZ 100: A-C

The POZ 100: D-F

The POZ 100: G-H

The POZ 100: J-L

The POZ 100: M-O

The POZ 100: P-R

The POZ 100: S-T

The POZ 100: V-Z

Positive Networks

From the Editor

Your Song

Feedback

Letters-December 2013

The POZ Q+A

Fire in the Blood

POZ Planet

Law of Desire

Do Some Men Want to Get AIDS?

Rocky Road

Public Knowledge

First in the Fight

Remembrance of Things Past

That ’80s Show

Say What? Lee Daniels Edition

Voices

Remembering J.C. Suares

Care and Treatment

Now Available: New Integrase Inhibitor

‘Quad’ as Effective as Older Options, Fewer Side Effects

Does HIV Make Addiction More Insidious?

TB Preventative Therapy Lowers Deaths by One Third

FDA OKs First Rapid Test for Acute HIV

GMHC Treatment Issues December 2013

Research Notes

Prevention: Malaria Vaccine Shows Promise

Treatment: Soybean Compound May Fight HIV

Cure: Drug-Free Viral Control in Monkeys

Concerns: Lymphoma Survival Unimproved

POZ Survey Says

Your Voice

POZ Heroes

A Mother’s Love

   
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

December 2013

Cure: Drug-Free Viral Control in Monkeys

by Benjamin Ryan

Adding both the arthritis drug auranofin and the chemotherapy agent buthionine sulfoximine to a highly intensified, five-drug antiretroviral (ARV) regimen appears to have led to a drug-free control of HIV in macaque monkeys. After researchers stopped all therapy, the monkeys at first experienced a viral rebound, but they eventually experienced a significant drop in a key indicator of their viral reservoir, as compared with levels measured before they began ARV treatment. The monkeys eventually achieved enough control of their infections to prevent the development of AIDS. The researchers found that the presence of CD8 cells as well as an enhanced level of cellular immune response among the monkeys played an important role in this apparent success. They hope to start a human clinical trial of this approach in early 2014.

Search: cure, monkeys, antiretrovirals, ARVs

Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chrisf
    san jose
    California


    Loveladyd
    Washington
    DC


    latinpozdallas
    Dallas
    Texas


    RayOctober
    Richmond
    Virginia
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Is HIV/AIDS adequately portrayed in pop culture?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.